← Leaderboards
David P Chimento
Rockland Immunochemicals, Inc.
$714,072
Attributed
$714,072
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $449.4K · FY2014–16$500K$375K$250K$125K$0
'14
'15
'16
Funding mix
By agency
NIH$714,072 · 2
By mechanism
R43$714,072 · 2
Top collaborators
No co-investigators on record.
Most similar at Rockland Immunochemicals, Inc.
Same institution · by research overlap
- Hiep T Tran$7,949,125
Others in their field
Top investigators on “Performance”
- Jeffrey P Krischer · University Of South Florida$413,069,911
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$378,749,497
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Lawrence Corey · Fred Hutchinson Cancer Center$319,618,139
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
Research focus
PerformanceReagentAntibodiesFutureDetectionBaseEpitopesEquipmentEuropeChildDropsElectrophoresisAbstractingEndemic DiseasesDiagnosticDiagnostic ProcedureDefectBlood SpecimenDevicesDiagnosisBloodCommercializationCostCross Reactivity
Grant awards (4)
Developing a Point-of-Care Device for the Diagnosis of Sickle Cell Disease in Low Resource Settings$40,000
R43 · FY2016 · HL · contact PI
Antibody-based Point-of-Care Device for the Diagnosis of Sickle Cell Disease$224,635
R43 · FY2015 · HL · contact PI
Synthetic antibodies for monitoring modified RNAs$225,000
R43 · FY2014 · DA · contact PI
Antibody-based Point-of-Care Device for the Diagnosis of Sickle Cell Disease$224,437
R43 · FY2014 · HL · contact PI